Selective Regain of Egfr Gene Copies in CD44+/CD24-/lowbreast Cancer Cellular Model MDA-MB-468

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-10-78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Regulation and Mechanisms of EGFR-mediated Apoptosis in MDA-MB-468 Cells.

English

Hypoxia-Induced Reactive Oxygen Species Mediate N-Cadherin and SERPINE1 Expression, EGFR Signalling and Motility in MDA-MB-468 Breast Cancer Cells

Scientific Reports
Multidisciplinary
2017English

YC-1 Exerts Inhibitory Effects on MDA-MB-468 Breast Cancer Cells by Targeting EGFR in Vitro and in Vivo Under Normoxic Condition

Chinese Journal of Cancer
2012English

Proteomics Analysis of siRNA-mediated Silencing of Wilms’ Tumor 1 in the MDA-MB-468 Breast Cancer Cell Line

Oncology Reports
MedicineCancer ResearchOncology
2014English

EGFR Signaling Pathways Are Wired Differently in Normal 184A1L5 Human Mammary Epithelial and MDA-MB-231 Breast Cancer Cells

Journal of Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Silencing of Bach1 Gene by Small Interfering RNA–mediation Regulates Invasive and Expression Level of miR-203, miR-145, Matrix Metalloproteinase-9, and CXCR4 Receptor in MDA-MB-468 Breast Cancer Cells

Tumor Biology
MedicineCancer Research
2017English

Growth and Molecular Interactions of the Anti-Egfr Antibody Cetuximab and the DNA Cross-Linking Agent Cisplatin in Gefitinib-Resistant MDA-MB-468 Cells: New Prospects in the Treatment of Triple-Negative/Basal-Like Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
1992English

Cell Migration Induced by Native Type IV Collagen Requires PI3K/Akt2 and EGFR Activity in MDA-MB-231 Breast Cancer Cells

Cancer Research Journal
2015English

Ginsenoside Rg3Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells

Journal of Cancer Prevention
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy